Life Science Leader - Home Page
WEBVolastra Therapeutics is a drug discovery and development leader in the emerging field of chromosomal instability, a phenomenon that can determine how certain solid tumor cancer cells replicate and grow. OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in ...
Rob Wright - Life Science Leader Editor
WEBJan 4, 2022 · Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of …
How Tony Robbins Became An Investor In Celularity - Life Science …
WEBJul 22, 2019 · According to Hariri, Robbins went overseas to get cell therapy treatments, and found the experience so life altering that he has almost become evangelical about what it can do. “That’s one of the reasons why he became an investor in Celularity,” Hariri contends. Robert Hariri, M.D., Ph.D., discusses how he became friends with life coach ...
Wayne Koberstein - Life Science Leader Editor
WEBFeb 1, 2024 · Wayne Koberstein. Wayne Koberstein is a 30-year veteran of the publishing industry, with extensive experience in publishing, communications, and business development. Wayne has interviewed and profiled more than 300 top executives in pharmaceutical companies, as well as major regulatory and …
Maximizing Pharma Partnerships Dos And Don'ts From Industry …
WEBMar 2, 2015 · In addition to the validation, Big Pharma partnerships also reduce risk for a small company, cutting the R&D burn rate and allowing the company to tap into the resources of a much larger company. Of course, structuring these deals is all part of the negotiating process. And while Big Pharma has a lot …
FSP Or Full-Service Outsourcing For Clinical Trials? - Life Science …
WEBDec 3, 2013 · Functional service provider (FSP) partnerships have been gaining traction in recent years because of their potential to increase efficiency and flexibility in outsourcing without compromising quality. Well-defined services within the scope of a clinical trial project or program (e.g. data management, biostatistics, or medical writing) are good ...
Life Sciences Industry On Uptick In Virginia
WEBMay 1, 2019 · The numbers of biopharmaceutical companies and medical device and equipment companies increased by 37 and 31 percent respectively during 2014 to 2016. “The life sciences industry is on the uptick in Virginia,” says Gallagher. Most Virginia bioscience companies are locally grown, created by the state’s entrepreneurs or …
Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare …
WEBGaurav Shah, M.D., is the CEO of Rocket Pharmaceuticals, a publicly traded (NASDAQ: RCKT) biopharmaceutical company. “We’re a relatively new company, about four years old, with four programs already in the clinic and another on the way,” he says. Being a platform agnostic gene therapy company, Rocket’s primary focus is on some rather ...
Singapore's Evolution To A Top Phase 1 Trial Destination
WEBThe country plays a substantial role in conducting Phase 1 studies in the Asia-Pacific region. Many pharmaceutical and biotech companies are now choosing to bring their innovative early-phase trials to Singapore over the more conventional options of the United States or Europe. This is largely due to the success stories during the last five years.
The Story Of Arrowhead Pharmaceuticals' Adversity Odyssey
WEBApr 1, 2020 · It was the summer of 2007 when Chris Anzalone, Ph.D., got a call from Arrowhead Research Company. At the time, Anzalone was working as CEO of the Bennet Group, a private equity firm in Washington, D.C., focused on creating and building new nanobiotechnology companies from university-generated science. “We talked about the deal, and then they ...